121 related articles for article (PubMed ID: 11366942)
1. Antiretrovirals for the heavily experienced patient: hefty plans to holidays.
Martinez LJ
Res Initiat Treat Action; 1999 Oct; 5(4):5-8. PubMed ID: 11366942
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Resistance testing debate: does it make the grade?
Simmons P
Res Initiat Treat Action; 1999 Oct; 5(4):9-12. PubMed ID: 11366943
[TBL] [Abstract][Full Text] [Related]
4. Abacavir for salvage or intensification.
Torres G
GMHC Treat Issues; 1999 Jan; 13(1):4-5. PubMed ID: 11366111
[TBL] [Abstract][Full Text] [Related]
5. New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini.
Mascolini M
J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):25-9. PubMed ID: 11367133
[TBL] [Abstract][Full Text] [Related]
6. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F
Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760
[TBL] [Abstract][Full Text] [Related]
7. [HIV and antiretroviral therapy: in every 3rd patient a virus rebound takes place].
Kunde K
Dtsch Med Wochenschr; 2000 Aug; 125(33):A10. PubMed ID: 11023348
[No Abstract] [Full Text] [Related]
8. Is Hydroxyurea for real?
Mascolini M
J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):6-16, 18. PubMed ID: 11365731
[TBL] [Abstract][Full Text] [Related]
9. Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Delaugerre C; Peytavin G; Dominguez S; Marcelin AG; Duvivier C; Gourlain K; Amellal B; Legrand M; Raffi F; Costagliola D; Katlama C; Calvez V
J Med Virol; 2005 Nov; 77(3):345-50. PubMed ID: 16173015
[TBL] [Abstract][Full Text] [Related]
10. Salvage solitaire (or, HAART takes a holiday).
Mascolini M
J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):10-23. PubMed ID: 11367132
[TBL] [Abstract][Full Text] [Related]
11. Drug failure and HIV resistance create frustrating scenarios for clinicians.
Murphy MJ
Fac Notes (New Orleans La); 1998; 10(5):1-3. PubMed ID: 11365830
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
13. HIV drug resistance and the other causes of treatment failure.
Schouten JT
STEP Perspect; 1997; 9(3):5-8. PubMed ID: 11364937
[TBL] [Abstract][Full Text] [Related]
14. Viral resistance: how it may affect treatment options.
Biehler GV
Body Posit; 1998 Jun; 11(6):42-3. PubMed ID: 11365610
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
Clevenbergh P; Boulmé R; Kirstetter M; Dellamonica P
HIV Med; 2004 Jul; 5(4):284-8. PubMed ID: 15236618
[TBL] [Abstract][Full Text] [Related]
16. Any toxic relief in sight? The induction/maintenance approach to therapy.
Gomez E
Newsline People AIDS Coalit N Y; 1998 Sep; ():33. PubMed ID: 11367488
[TBL] [Abstract][Full Text] [Related]
17. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.
Montroni M; Monforte AD
Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591
[TBL] [Abstract][Full Text] [Related]
18. HIV resistance-testing information on web.
AIDS Treat News; 2000 Feb; (No 337):6. PubMed ID: 11367209
[TBL] [Abstract][Full Text] [Related]
19. New principles of HIV-related medical care.
Deeks SG
Focus; 1997 Apr; 12(5):5-7. PubMed ID: 11364329
[TBL] [Abstract][Full Text] [Related]
20. Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV-1 resistance genotype.
Izopet J; Souyris C; Sandres-Sauné K; Puissant B; Obadia M; Pasquier C; Puel J; Blancher A; Massip P
J Med Virol; 2002 Nov; 68(3):305-10. PubMed ID: 12226815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
